Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Jazz Pharmaceuticals PLC (NASDAQ:JAZZ)

167.71
Delayed Data
As of Sep 02
 +2.78 / +1.69%
Today’s Change
137.34
Today|||52-Week Range
194.73
+2.43%
Year-to-Date

Today’s Trading

Previous close164.93
Today’s open167.94
Day’s range163.47 - 168.61
Volume333,180
Average volume (3 months)438,207
Market cap$10.1B
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)-73.50%
Earnings growth (this year)+14.62%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+34.44%
P/E ratio40.7
Price/Sales8.74
Price/Book7.29

Competitors

 Today’s
change
Today’s
% change
MNKMallinckrodt Plc+0.31+0.37%
RDYDr.Reddy's Laborator...+0.78+1.22%
ALKSAlkermes Plc+3.70+6.23%
MDVNMedivation Inc+3.98+4.65%
Data as of 4:02pm ET, 09/02/2015

Financials

Next reporting dateNovember 3, 2015
EPS forecast (this quarter)$2.56
Annual revenue (last year)$1.2B
Annual profit (last year)$58.4M
Net profit margin4.98%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
Bruce C. Cozadd
Chief Operating Officer &
Executive Vice President
Russell J. Cox
Corporate headquarters
Dublin, Dublin

Forecasts

Partner Offers